Myriad Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$3.12M Buy
10,900
+3,600
+49% +$926K 0.43% 26
2021
Q4
$2.02M Hold
7,300
0.22% 66
2021
Q3
$1.69M Buy
7,300
+4,100
+128% +$1.01M 0.17% 88
2021
Q2
$734K Buy
+3,200
New +$643K 0.05% 110

Other funds holding LLY

Myriad Asset Management's LLY Position: Q1 2022 in Review

Myriad Asset Management increased its Eli Lilly (LLY) stake by 49% in Q1 2022, buying an estimated $926K and bringing the position to 10,900 shares worth $3.12M. The position accounts for 0.43% of the portfolio, ranked #26.

Myriad Asset Management first reported a position in LLY in Q2 2021 and has held it in 4 quarters since. 2,343 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Myriad Asset Management held 10,900 shares of Eli Lilly worth $3.12M as of Q1 2022.
  • Myriad Asset Management bought 3,600 Eli Lilly shares in Q1 2022, an estimated $926K.
  • Eli Lilly made up 0.43% of Myriad Asset Management's portfolio in Q1 2022, its #26 holding.
  • Myriad Asset Management first reported a position in Eli Lilly in Q2 2021 and has held it in 4 quarters since.
  • 2,343 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Myriad Asset Management's 13F filing for Q1 2022, filed 16 May 2022.